Table 1 Comparison of patient characteristics according to vascular invasion
Characteristics | Total | MVI | Grade | ||||
|---|---|---|---|---|---|---|---|
Negative | Positive | P | Low | High | P | ||
Age | 175 | 54.339 (10.584) | 53.383 (10.742) | 0.573 | 52.250 (10.606) | 54.677 (10.587) | 0.1780 |
Recurrence (months) | 175 | 30.67 ± 23.43 | 22.18 ± 18.30 | 0.012 | 25.97 ± 20.67 | 21.72 ± 18.92 | 0.186 |
Metastasis (months) | 175 | 30.08 ± 23.67 | 21.76 ± 18.96 | 0.017 | 26.03 ± 21.33 | 20.22 ± 18.79 | 0.077 |
HBsAg | 0.080 | 0.590 | |||||
Negative | 26 | 21 (80.77) | 5 (19.23) | 6 (23.08) | 20 (76.92) | ||
Positive | 149 | 94 (63.09) | 55 (36.91) | 42 (28.19) | 107 (71.81) | ||
HBeAg | 0.706 | 0.266 | |||||
Negative | 117 | 78 (66.67) | 39 (33.33) | 29 (24.79) | 88 (75.21) | ||
Positive | 58 | 37 (63.79) | 21 (36.21) | 19 (32.76) | 39 (67.24) | ||
Cirrhosis | 0.522 | 0.011 | |||||
Negative | 46 | 32 (69.57) | 14 (30.43) | 6 (13.04) | 40 (86.96) | ||
Positive | 129 | 83 (64.34) | 46 (35.66) | 42 (32.56) | 87 (67.44) | ||
AFP (ng/L) | 0.002 | 0.030 | |||||
> 0 < 20 | 81 | 63 (77.78) | 18 (22.22) | 30(37.04) | 51 (62.96) | ||
> 20 < 400 | 58 | 36 (62.07) | 22 (37.93) | 11 (18.97) | 47 (81.03) | ||
≥ 400 | 36 | 16 (44.44) | 20 (55.56) | 7 (19.44) | 29 (80.56) | ||
MRI feature | |||||||
Tumor Number | 0.005 | 0.019 | |||||
Single | 145 | 102 (70.34) | 43 (29.66) | 45 (31.03) | 100 (68.97) | ||
Multiple | 30 | 13 (43.33) | 17 (56.67) | 3 (10.00) | 27 (90.00) | ||
Tumor size (cm) | 0.030 | 0.979 | |||||
< 5 | 131 | 92 (70.23) | 39 (29.77) | 36 (27.48) | 95 (72.52) | ||
≥ 5 | 44 | 23 (52.27) | 21 (47.73) | 12 (27.27) | 32 (72.73) | ||
Capsule | 0.020 | 0.011 | |||||
Negative | 117 | 70 (59.83) | 47 (40.17) | 25 (21.37) | 92 (78.63) | ||
Positive | 58 | 45 (77.59) | 13 (22.41) | 23 (39.66) | 35 (60.34) | ||
Lipid | 0.609 | 0.078 | |||||
Negative | 121 | 81 (66.94) | 40 (33.06) | 38 (31.40) | 83 (68.60) | ||
Positive | 54 | 34 (62.96) | 20 (37.04) | 10 (18.52) | 44 (81.48) | ||
Arterial rim enhancement | 0.001 | 0.451 | |||||
Negative | 94 | 72 (76.60) | 22 (23.40) | 28 (29.79) | 66 (70.21) | ||
Positive | 81 | 43 (53.09) | 38 (46.91) | 20 (24.69) | 61 (75.31) | ||
Arterial peritumoral enhancement | < 0.001 | 0.396 | |||||
Negative | 152 | 111 (73.03) | 41 (26.97) | 40 (26.32) | 112 (73.68) | ||
Positive | 23 | 4 (17.39) | 19 (82.61) | 8 (34.78) | 15 (65.22) | ||
Tumor margin | < 0.001 | 0.883 | |||||
Smooth | 75 | 61 (81.33) | 14 (18.67) | 21 (28.00) | 54 (72.00) | ||
Non-smooth | 100 | 54 (54.00) | 46 (46.00) | 27 (27.00) | 73 (73.00) | ||
Tumor hypointensity on HBP | 0.291 | 0.177 | |||||
Yes | 161 | 104 (64.60) | 57 (35.40) | 42 (26.09) | 119 (73.91) | ||
No | 14 | 11 (78.57) | 3 (21.43) | 6 (42.86) | 8 (57.14) | ||
Peritumoral hypointensity on HBP | < 0.001 | 0.178 | |||||
Absent | 146 | 106 (72.60) | 40 (27.40) | 43 (29.45) | 103 (70.55) | ||
Present | 29 | 9 (31.03) | 20 (68.97) | 5 (17.24) | 24 (82.76) | ||
Shape | 0.854 | 0.044 | |||||
Round | 58 | 40 (68.97) | 18 (31.03) | 23 (39.66) | 35 (60.34) | ||
Oval | 20 | 14 (70.00) | 6 (30.00) | 6 (30.00) | 14 (70.00) | ||
Lobulated | 65 | 41 (63.08) | 24 (36.92) | 11 (16.92) | 54 (83.08) | ||
I rregular | 32 | 20 (62.50) | 12 (37.50) | 8 (25.00) | 24 (75.00) | ||